A detailed history of Global Retirement Partners, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Global Retirement Partners, LLC holds 175 shares of BPMC stock, worth $16,954. This represents 0.0% of its overall portfolio holdings.

Number of Shares
175
Previous 175 -0.0%
Holding current value
$16,954
Previous $18,000 11.11%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$85.18 - $108.78 $1,362 - $1,740
16 Added 10.06%
175 $18,000
Q4 2023

Jan 18, 2024

BUY
$43.96 - $92.84 $483 - $1,021
11 Added 7.43%
159 $14,000
Q1 2023

May 05, 2023

BUY
$37.97 - $50.0 $5,619 - $7,400
148 New
148 $6,000

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.79B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Global Retirement Partners, LLC Portfolio

Follow Global Retirement Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Retirement Partners, LLC with notifications on news.